Adamas Pharmaceuticals, Inc. Financial Statements 2011-2024 | ADMS

Annual Financial Statements Adamas Pharmaceuticals, Inc.

	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	164 M	141 M	239 M	886 M	323 M	310 M	250 M	-	-	-
Shares	27.7 M	27.7 M	26.9 M	22.6 M	21.7 M	18.1 M	14.8 M	-	-	-
Net Income	-57.4 M	-105 M	-131 M	-89.5 M	-60.1 M	-51.8 M	10.2 M	50.9 M	17.7 M	-
Revenue	74.5 M	54.6 M	34 M	571 K	572 K	1.92 M	55.8 M	71.1 M	37.5 M	-
EBITDA	-43.3 M	-91 M	-114 M	-86.7 M	-60.2 M	-57 M	18.7 M	57.1 M	20 M	-
Operating Expenses	117 M	144 M	148 M	88.5 M	61.6 M	59.4 M	37.3 M	14.1 M	17.5 M	-
General and Administrative Expenses	107 M	114 M	109 M	61.3 M	30.3 M	23.5 M	15.5 M	6.67 M	8.33 M	-

All numbers in USD currency